BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23974304)

  • 1. Radiosynthesis and in vivo evaluation of a ¹⁸F-labelled styryl-benzoxazole derivative for β-amyloid targeting.
    Ribeiro Morais G; Gano L; Kniess T; Bergmann R; Abrunhosa A; Santos I; Paulo A
    Appl Radiat Isot; 2013 Dec; 82():100-4. PubMed ID: 23974304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel ¹⁸F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in Alzheimer's disease.
    Cui M; Ono M; Kimura H; Ueda M; Nakamoto Y; Togashi K; Okamoto Y; Ihara M; Takahashi R; Liu B; Saji H
    J Med Chem; 2012 Nov; 55(21):9136-45. PubMed ID: 22690944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of novel ¹⁸F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques.
    Cui M; Wang X; Yu P; Zhang J; Li Z; Zhang X; Yang Y; Ono M; Jia H; Saji H; Liu B
    J Med Chem; 2012 Nov; 55(21):9283-96. PubMed ID: 22974116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
    Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
    Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of 18F-labeled 2-phenylbenzothiazoles as positron emission tomography imaging agents for amyloid plaques in Alzheimer's disease.
    Serdons K; Terwinghe C; Vermaelen P; Van Laere K; Kung H; Mortelmans L; Bormans G; Verbruggen A
    J Med Chem; 2009 Mar; 52(5):1428-37. PubMed ID: 19216563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (18)F-Labeled benzylideneaniline derivatives as new ligands for beta-amyloid plaque imaging in Alzheimer's disease.
    Lee HJ; Jeong JM; Rai G; Lee YS; Chang YS; Kim YJ; Kim HW; Lee DS; Chung JK; Mook-Jung I; Lee MC
    Nucl Med Biol; 2009 Feb; 36(2):107-16. PubMed ID: 19217522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as ¹⁸F-PET imaging agents for β-amyloid plaques.
    Swahn BM; Sandell J; Pyring D; Bergh M; Jeppsson F; Juréus A; Neelissen J; Johnström P; Schou M; Svensson S
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4332-7. PubMed ID: 22647721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
    Lee I; Yang J; Lee JH; Choe YS
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5765-9. PubMed ID: 21885280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.
    Lister-James J; Pontecorvo MJ; Clark C; Joshi AD; Mintun MA; Zhang W; Lim N; Zhuang Z; Golding G; Choi SR; Benedum TE; Kennedy P; Hefti F; Carpenter AP; Kung HF; Skovronsky DM
    Semin Nucl Med; 2011 Jul; 41(4):300-4. PubMed ID: 21624563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dual fluorinated and iodinated radiotracer for PET and SPECT imaging of β-amyloid plaques in the brain.
    Watanabe H; Ono M; Kimura H; Kagawa S; Nishii R; Fuchigami T; Haratake M; Nakayama M; Saji H
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6519-22. PubMed ID: 21920750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 18F-labeled BF-227 derivative as a potential radioligand for imaging dense amyloid plaques by positron emission tomography.
    Furumoto S; Okamura N; Furukawa K; Tashiro M; Ishikawa Y; Sugi K; Tomita N; Waragai M; Harada R; Tago T; Iwata R; Yanai K; Arai H; Kudo Y
    Mol Imaging Biol; 2013 Aug; 15(4):497-506. PubMed ID: 23362000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains.
    Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of N-methyl and S-methyl 11C-labeled 6-methylthio-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridines as radioligands for imaging beta-amyloid plaques in Alzheimer's disease.
    Cai L; Liow JS; Zoghbi SS; Cuevas J; Baetas C; Hong J; Shetty HU; Seneca NM; Brown AK; Gladding R; Temme SS; Herman MM; Innis RB; Pike VW
    J Med Chem; 2008 Jan; 51(1):148-58. PubMed ID: 18078311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain.
    Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF
    J Med Chem; 2005 Sep; 48(19):5980-8. PubMed ID: 16162001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99m)Tc-labeled-2-arylbenzoxazole derivatives as potential Aβ imaging probes for single-photon emission computed tomography.
    Wang X; Cui M; Jia J; Liu B
    Eur J Med Chem; 2015 Jan; 89():331-9. PubMed ID: 25462249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3'-Me-BTA-1 as potential radiotracers for in vivo imaging of beta-amyloid plaques.
    Neumaier B; Deisenhofer S; Fürst D; von Arnim CA; Thees S; Buck AK; Glatting G; Landwehrmeyer GB; Krause BJ; Müller HD; Sommer C; Reske SN; Mottaghy FM
    Nuklearmedizin; 2007; 46(6):271-80. PubMed ID: 18084683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.
    Kepe V; Huang SC; Small GW; Satyamurthy N; Barrio JR
    Methods Enzymol; 2006; 412():144-60. PubMed ID: 17046657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection.
    Fawaz MV; Brooks AF; Rodnick ME; Carpenter GM; Shao X; Desmond TJ; Sherman P; Quesada CA; Hockley BG; Kilbourn MR; Albin RL; Frey KA; Scott PJ
    ACS Chem Neurosci; 2014 Aug; 5(8):718-30. PubMed ID: 24896980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.
    Chen X; Fritz A; Werner RA; Nose N; Yagi Y; Kimura H; Rowe SP; Koshino K; Decker M; Higuchi T
    Mol Imaging Biol; 2020 Jun; 22(3):602-611. PubMed ID: 31332629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of benzothiophene derivatives as ligands for imaging beta-amyloid plaques in Alzheimer's disease.
    Chang YS; Jeong JM; Lee YS; Kim HW; Ganesha RB; Kim YJ; Lee DS; Chung JK; Lee MC
    Nucl Med Biol; 2006 Aug; 33(6):811-20. PubMed ID: 16934700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.